These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17925434)

  • 1. Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer.
    Kendall J; Liu Q; Bakleh A; Krasnitz A; Nguyen KC; Lakshmi B; Gerald WL; Powers S; Mu D
    Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16663-8. PubMed ID: 17925434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both gene amplification and allelic loss occur at 14q13.3 in lung cancer.
    Harris T; Pan Q; Sironi J; Lutz D; Tian J; Sapkar J; Perez-Soler R; Keller S; Locker J
    Clin Cancer Res; 2011 Feb; 17(4):690-9. PubMed ID: 21148747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
    Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
    Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer.
    Hsu DS; Acharya CR; Balakumaran BS; Riedel RF; Kim MK; Stevenson M; Tuchman S; Mukherjee S; Barry W; Dressman HK; Nevins JR; Powers S; Mu D; Potti A
    Proc Natl Acad Sci U S A; 2009 Mar; 106(13):5312-7. PubMed ID: 19279207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite roles of FOXA1 and NKX2-1 in lung cancer progression.
    Deutsch L; Wrage M; Koops S; Glatzel M; Uzunoglu FG; Kutup A; Hinsch A; Sauter G; Izbicki JR; Pantel K; Wikman H
    Genes Chromosomes Cancer; 2012 Jun; 51(6):618-29. PubMed ID: 22383183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer.
    Kim YH; Kwei KA; Girard L; Salari K; Kao J; Pacyna-Gengelbach M; Wang P; Hernandez-Boussard T; Gazdar AF; Petersen I; Minna JD; Pollack JR
    Oncogene; 2010 Mar; 29(10):1421-30. PubMed ID: 19966867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer.
    Kwei KA; Kim YH; Girard L; Kao J; Pacyna-Gengelbach M; Salari K; Lee J; Choi YL; Sato M; Wang P; Hernandez-Boussard T; Gazdar AF; Petersen I; Minna JD; Pollack JR
    Oncogene; 2008 Jun; 27(25):3635-40. PubMed ID: 18212743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the cancer genome in lung adenocarcinoma.
    Weir BA; Woo MS; Getz G; Perner S; Ding L; Beroukhim R; Lin WM; Province MA; Kraja A; Johnson LA; Shah K; Sato M; Thomas RK; Barletta JA; Borecki IB; Broderick S; Chang AC; Chiang DY; Chirieac LR; Cho J; Fujii Y; Gazdar AF; Giordano T; Greulich H; Hanna M; Johnson BE; Kris MG; Lash A; Lin L; Lindeman N; Mardis ER; McPherson JD; Minna JD; Morgan MB; Nadel M; Orringer MB; Osborne JR; Ozenberger B; Ramos AH; Robinson J; Roth JA; Rusch V; Sasaki H; Shepherd F; Sougnez C; Spitz MR; Tsao MS; Twomey D; Verhaak RG; Weinstock GM; Wheeler DA; Winckler W; Yoshizawa A; Yu S; Zakowski MF; Zhang Q; Beer DG; Wistuba II; Watson MA; Garraway LA; Ladanyi M; Travis WD; Pao W; Rubin MA; Gabriel SB; Gibbs RA; Varmus HE; Wilson RK; Lander ES; Meyerson M
    Nature; 2007 Dec; 450(7171):893-8. PubMed ID: 17982442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIS is an oncogene amplified in squamous cell carcinoma.
    Hibi K; Trink B; Patturajan M; Westra WH; Caballero OL; Hill DE; Ratovitski EA; Jen J; Sidransky D
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5462-7. PubMed ID: 10805802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer.
    Medina PP; Castillo SD; Blanco S; Sanz-Garcia M; Largo C; Alvarez S; Yokota J; Gonzalez-Neira A; Benitez J; Clevers HC; Cigudosa JC; Lazo PA; Sanchez-Cespedes M
    Hum Mol Genet; 2009 Apr; 18(7):1343-52. PubMed ID: 19153074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site-amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene.
    Lin L; Aggarwal S; Glover TW; Orringer MB; Hanash S; Beer DG
    Cancer Res; 2000 Mar; 60(5):1341-7. PubMed ID: 10728696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
    Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; Orringer MB; Glover TW; Beer DG; Lin L
    Cancer Res; 2003 Jul; 63(14):4136-43. PubMed ID: 12874018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identical deletion at 14q13.3 including PAX9 and NKX2-1 in siblings from mosaicism of unaffected parent.
    Hayashi S; Yagi M; Morisaki I; Inazawa J
    J Hum Genet; 2015 Apr; 60(4):203-6. PubMed ID: 25608831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma.
    Enfield KSS; Marshall EA; Anderson C; Ng KW; Rahmati S; Xu Z; Fuller M; Milne K; Lu D; Shi R; Rowbotham DA; Becker-Santos DD; Johnson FD; English JC; MacAulay CE; Lam S; Lockwood WW; Chari R; Karsan A; Jurisica I; Lam WL
    Nat Commun; 2019 Nov; 10(1):5438. PubMed ID: 31780666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes.
    Dai Z; Zhu WG; Morrison CD; Brena RM; Smiraglia DJ; Raval A; Wu YZ; Rush LJ; Ross P; Molina JR; Otterson GA; Plass C
    Hum Mol Genet; 2003 Apr; 12(7):791-801. PubMed ID: 12651874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene amplification at chromosome 1pter-p33 including the genes PAX7 and ENO1 in squamous cell lung carcinoma.
    Rácz A; Brass N; Höfer M; Sybrecht GW; Remberger K; Meese EU
    Int J Oncol; 2000 Jul; 17(1):67-73. PubMed ID: 10853020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of Nkx2.1 and Pax9 for calcitonin gene transcription.
    Suzuki M; Katagiri N; Ueda M; Tanaka S
    Gen Comp Endocrinol; 2007; 152(2-3):259-66. PubMed ID: 17412341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refined physical map of the human PAX2/HOX11/NFKB2 cancer gene region at 10q24 and relocalization of the HPV6AI1 viral integration site to 14q13.3-q21.1.
    Gough SM; McDonald M; Chen XN; Korenberg JR; Neri A; Kahn T; Eccles MR; Morris CM
    BMC Genomics; 2003 Mar; 4(1):9. PubMed ID: 12697057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Cis-regulatory elements in the mouse Pax9/Nkx2-9 genomic region: implication for evolutionary conserved synteny.
    Santagati F; Abe K; Schmidt V; Schmitt-John T; Suzuki M; Yamamura K; Imai K
    Genetics; 2003 Sep; 165(1):235-42. PubMed ID: 14504231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent overexpression of the genes FXR1, CLAPM1 and EIF4G located on amplicon 3q26-27 in squamous cell carcinoma of the lung.
    Comtesse N; Keller A; Diesinger I; Bauer C; Kayser K; Huwer H; Lenhof HP; Meese E
    Int J Cancer; 2007 Jun; 120(12):2538-44. PubMed ID: 17290396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.